Use of Botulinum Toxin and Pneumoperitoneum for Hernias with Loss of Dominance

Abstract

When the abdominal cavity's material migrates to the hernial sac (HSV) and the HSV/abdominal cavity volume ratio exceeds 25%, systemic alterations known as "loss of domain" occur, resulting in an estimated 5–30% of cases of post-incisional ventral hernia. Usage of botulinum toxin appears to be a secure way to do a tension-free repair on treatment for hernias with loss of dominance.